RECRUITING

UNC Pleural Fluid Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Research with biospecimens such as blood, tissue, or body fluids can help researchers understand how the human body works. Researchers can make new tests to find diseases, understand how treatments work, or find new ways to treat a disease. The purpose of this study is to collect biospecimens for research from patients with known or suspected lung cancer. The information learned from the biospecimens may be used in future treatments. The purpose of this protocol is to create a pleural fluid registry for use in future studies.

Official Title

University of North Carolina Pleural Fluid Registry

Quick Facts

Study Start:2018-01-24
Study Completion:2050-01-24
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05620329

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients who are 18 years or older
  2. * Inpatients and outpatients
  3. * Diagnosed with pleural fluid, are referred for and undergo clinically indicated drainage who have clinical evidence of:
  4. * pulmonary infection (such as fever, leukocytosis, new or worsening infiltrate on chest x-ray, or clinical deterioration) with effusion
  5. * malignancy
  1. * A subject will not be eligible for inclusion in this registry if, in the investigator's (or treating clinician's) opinion, the patient has any concurrent medical condition that may preclude their ability to undergo pleural fluid drainage safely.
  2. * Incarcerated individuals

Contacts and Locations

Study Contact

Carmmen Garcia
CONTACT
+1 954-336-7499
carmmene@med.unc.edu
Luz Cuaboy
CONTACT
+1 954-336-7499
luz_cuaboy@med.unc.edu

Principal Investigator

Jason Akulian
PRINCIPAL_INVESTIGATOR
UNC Lineberger Comprehensive Cancer Center

Study Locations (Sites)

UNC Lingeberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27599
United States

Collaborators and Investigators

Sponsor: UNC Lineberger Comprehensive Cancer Center

  • Jason Akulian, PRINCIPAL_INVESTIGATOR, UNC Lineberger Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-01-24
Study Completion Date2050-01-24

Study Record Updates

Study Start Date2018-01-24
Study Completion Date2050-01-24

Terms related to this study

Keywords Provided by Researchers

  • biospecimen
  • pleural fluid
  • lung cancer
  • cancer
  • infection
  • breast cancer

Additional Relevant MeSH Terms

  • Lung Cancer
  • Lung Infection
  • Breast Cancer
  • Malignant Pleural Effusion
  • Empyema